IQVIA Holdings Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Public

  • Employees
  • 95,000

Employees

  • Stock Symbol
  • IQV

Stock Symbol

  • Investments
  • 125

  • Share Price
  • $250.55
  • (As of Thursday Closing)

IQVIA Holdings General Information

Description

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Contact Information

Website
www.iqvia.com
Formerly Known As
Quintiles IMS Holdings, Quintiles Transnational Holdings
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 2400 Ellis Road
  • Durham, NC 27703
  • United States
+1 (919)
Primary Industry
Other Healthcare Services
Other Industries
Media and Information Services (B2B)
Enterprise Systems (Healthcare)
IT Consulting and Outsourcing
Stock Exchange
NYS
Corporate Office
  • 2400 Ellis Road
  • Durham, NC 27703
  • United States
+1 (919)

IQVIA Holdings Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IQVIA Holdings Stock Performance

As of 19-Nov-2026, IQVIA Holdings’s stock price is $250.55. Its current market cap is $41.3B with 165M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$250.55 $257.84 $154.50 - $284.50 $41.3B 165M 1.45M $8.31

IQVIA Holdings Financials Summary

As of 30-Sep-2026, IQVIA Holdings has a trailing 12-month revenue of $17.3B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 58,543,710 51,733,323 47,654,565 54,742,850
Revenue 17,311,000 16,310,000 15,405,000 14,984,000
EBITDA 3,515,000 3,419,000 3,406,000 3,220,000
Net Income 1,394,000 1,360,000 1,373,000 1,358,000
Total Assets 30,474,000 29,944,000 26,899,000 26,681,000
Total Debt 16,314,000 15,949,000 14,156,000 13,896,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IQVIA Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IQVIA Holdings‘s full profile, request access.

Request a free trial

IQVIA Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 fro
Other Healthcare Services
Durham, NC
95,000 As of 2026

Morrisville, NC
 

Radnor, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IQVIA Holdings Competitors (28)

One of IQVIA Holdings’s 28 competitors is Syneos Health, a Private Equity-Backed company based in Morrisville, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Syneos Health Private Equity-Backed Morrisville, NC
Certara Formerly PE-Backed Radnor, PA
Icon (Dublin) Corporation Dublin, Ireland
Premier Research Private Equity-Backed Morrisville, NC
Veeva Systems Formerly VC-backed Pleasanton, CA
You’re viewing 5 of 28 competitors. Get the full list »

IQVIA Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IQVIA Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IQVIA Holdings‘s full profile, request access.

Request a free trial

IQVIA Holdings Investments & Acquisitions (125)

IQVIA Holdings’s most recent deal was a Merger/Acquisition with Reverba Global. The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Reverba Global 01-Oct-2026 Merger/Acquisition Enterprise Systems (Healthcare)
ZephyRx 01-Aug-2026 Merger/Acquisition Other Healthcare Technology Systems
Charles River Laboratories International (European Discovery Services Assets) 25-Feb-2026 Corporate Asset Purchase Buildings and Property
Cedar Gate Technologies 01-Dec-2025 Merger/Acquisition Enterprise Systems (Healthcare)
Throtle 13-Nov-2025 Merger/Acquisition Media and Information Services (B2B)
You’re viewing 5 of 125 investments and acquisitions. Get the full list »

IQVIA Holdings ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

17.13 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 67

Rank

Percentile

To view IQVIA Holdings’s complete esg history, request access »

IQVIA Holdings Exits (17)

IQVIA Holdings’s most recent exit was on 13-Feb-2018 from COTA. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
COTA 13-Feb-2018 Completed
  • 7 buyers
HighPoint Solutions 02-Oct-2017 Completed
Encore Health Resources 01-Jul-2014 Completed
  • 7 buyers
EUSA Pharma (UK) 14-Mar-2008 Completed
  • 15 buyers
EUSA Pharma (UK) 01-Mar-2007 PE Growth/Expansion Completed
  • 7 buyers
You’re viewing 5 of 17 exits. Get the full list »

IQVIA Holdings Affiliates

Subsidiaries (42)

Name Industry Location Year Founded
Lasso Marketing Austin, TX 2019
Radar Acquisition Blocker Durham, NC 2019
ZephyRx Troy, NY 2019
Next Oncology San Antonio, TX 2018
COGVIO Prague, Czech Republic 2017
You’re viewing 5 of 42 affiliates. Get the full list.  »

IQVIA Holdings FAQs

  • When was IQVIA Holdings founded?

    IQVIA Holdings was founded in 1982.

  • Where is IQVIA Holdings headquartered?

    IQVIA Holdings is headquartered in Durham, NC.

  • What is the size of IQVIA Holdings?

    IQVIA Holdings has 95,000 total employees.

  • What industry is IQVIA Holdings in?

    IQVIA Holdings’s primary industry is Other Healthcare Services.

  • Is IQVIA Holdings a private or public company?

    IQVIA Holdings is a Public company.

  • What is IQVIA Holdings’s stock symbol?

    The ticker symbol for IQVIA Holdings is IQV.

  • What is the current stock price of IQVIA Holdings?

    As of 19-Nov-2026 the stock price of IQVIA Holdings is $250.55.

  • What is the current market cap of IQVIA Holdings?

    The current market capitalization of IQVIA Holdings is $41.3B.

  • What is IQVIA Holdings’s current revenue?

    The trailing twelve month revenue for IQVIA Holdings is $17.3B.

  • Who are IQVIA Holdings’s competitors?

    Syneos Health, Certara, Icon (Dublin), Premier Research, and Veeva Systems are some of the 28 competitors of IQVIA Holdings.

  • What is IQVIA Holdings’s annual earnings per share (EPS)?

    IQVIA Holdings’s EPS for 12 months was $8.31.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process